SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
______________
Date of Report (Date of earliest event reported): November 9, 2001
MYRIAD GENETICS, INC.
(Exact name of registrant as specified in its charter)
Delaware 0-26642 87-0494517
- --------------- ------------ -------------------
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification No.)
incorporation) xx-xxxxxxx
320 Wakara Way
Salt Lake City, Utah 84108
--------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (801) 584-3600
-------------------------------------------------------------
(Former name or former address, if changed since last report)
Page 1 of 4 pages
Item 5. Other Events.
On November 9, 2001, the Registrant publicly disseminated a press
release announcing that the Registrant has filed a Form S-3 shelf registration
statement with the Securities and Exchange Commission for the sale of up to $250
million of various types of securities. The information contained in the press
release is incorporated herein by reference and filed as Exhibit 99.1 hereto.
Item 7. Financial Statements and Exhibits.
(c) Exhibits.
99.1 The Registrant's Press Release dated November 9, 2001.
Page 2 of 4 pages
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Myriad Genetics, Inc.
---------------------
(Registrant)
Date: November 9, 2001 By: /s/ Peter D. Meldrum
------------------------
Peter D. Meldrum
President and Chief
Executive Officer
Page 3 of 4 pages
EXHIBIT INDEX
-------------
Exhibit
Number Description
- ------ -----------
99.1 The Registrant's Press Release
dated November 9, 2001.
Page 4 of 4 pages